What's breaking now, across thousands of outlets.
Spun out of research at Seattle Children’s Hospital, the startup has brought a CAR-T treatment for a rare and deadly pediatric cancer into mid-stage testing.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Researchers examined an association between dietary fat intake and mortality among patients with nonmetastatic prostate cancer.
[Health-e] When Lizeka Ngcozana's cousin had a stroke on a Tuesday morning, she took her to Ngonyama Clinic outside Cacadu in the Eastern Cape.
[Health-e] Two families in Nyakallong, Free State, are mourning the deaths of two young boys who drowned in a mine dam near Harmony Gold's Target 2 Rock Dump in Allanridge.
Survival rates for childhood cancer now exceed 80%—but this also means more children are living with the long-term emotional and psychosocial impacts of cancer.
BCB-276 is designed to treat diffuse intrinsic pontine glioma (DIPG) by targeting B7-H3, an immune checkpoint protein encoded by the CD276 gene that has been shown to be involved in tumor progression…
Two companies that have spent decades trying to develop cell therapies for diabetes are set to merge, with the aim of working together to take on a market also being pursued by Vertex and CRISPR ...
